Cleerly ISCHEMIA vs Viz AAA

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cleerly ISCHEMIA

by Cleerly

Viz AAA

by Viz.ai

AI Verdict

These tools are adjacent rather than direct competitors, as they both leverage AI for cardiovascular imaging analysis but target distinct pathologies. Cleerly ISCHEMIA focuses on detailed analysis of CCTA scans for coronary artery ischemia and plaque characterization, aiding in personalized diagnosis of heart disease. In contrast, Viz AAA specializes in the rapid detection and triage of suspected Abdominal Aortic Aneurysm from CTA scans, aiming to accelerate care coordination for this specific condition.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if your primary goal is a comprehensive, non-invasive assessment of coronary artery disease to determine the likelihood of ischemia at a vessel level. This tool is ideal for detailed plaque characterization, stenosis severity assessment, and guiding personalized treatment plans for patients with suspected or known stable coronary artery disease.

View Cleerly ISCHEMIA →

Choose Viz AAA if…

Choose Viz AAA if your priority is the rapid, AI-powered detection and urgent triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. This solution is best suited for accelerating diagnosis, streamlining care coordination through real-time alerts, and improving time-sensitive treatment decisions for acute aortic pathologies, particularly in emergency or high-volume settings.

View Viz AAA →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cleerly ISCHEMIA	Viz AAA
Pricing	Unknown	Enterprise (hospital/health system)
Deployment	Web-based solution	Cloud-based, integrates with PACS and EHR systems.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cleerly ISCHEMIA	Viz AAA
Tool Name	Cleerly ISCHEMIA	Viz AAA
Primary Purpose	Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease.	AI-powered solution for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination.
Company	Cleerly	Viz.ai
Target Medical Specialties	Cardiology, Radiology	Emergency Medicine, Radiology, Vascular Surgery
Core AI Analysis Focus	AI-enabled CCTA analysis, non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, coronary plaque characterization, stenosis severity assessment.	AI-powered automatic detection of suspected AAA from CTA scans, automated triage and prioritization of cases.
Key Output/Action	Comprehensive interactive web-based reports, 3D digital models of coronary arteries, integration with PowerScribe via API.	Real-time alerts to care teams, HIPAA-compliant communication platform for multidisciplinary teams, mobile access to high-fidelity imaging and patient information.

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and Viz AAA.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiovascular conditions do these AI tools help diagnose?

Cleerly ISCHEMIA is designed to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding in the diagnosis and treatment planning for heart disease. In contrast, Viz AAA is an AI-powered solution for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans.

What types of imaging scans are required for each tool's analysis?

Cleerly ISCHEMIA analyzes Coronary CT Angiography (CCTA) scans to provide its assessment of ischemia and coronary plaque characteristics. Viz AAA is designed to detect suspected AAA from CT angiography scans of the abdomen.

What are the primary outputs and key features a physician can expect from each AI tool?

Cleerly ISCHEMIA offers AI-enabled CCTA analysis, non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood, coronary plaque characterization, and 3D digital models. Viz AAA provides AI-powered automatic detection of suspected AAA, automated triage and prioritization of cases, real-time alerts to care teams, and a HIPAA-compliant communication platform.

Which medical specialties are the primary users of each AI solution?

Cleerly ISCHEMIA is primarily utilized by Cardiology and Radiology specialists. Viz AAA is designed to support Emergency Medicine, Radiology, and Vascular Surgery.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cleerly ISCHEMIA or Viz AAA

Backers

Who funded each tool's parent company.

Cleerly ISCHEMIA

Viz AAA

Scale Venture Partners